The Uromigos at ASCO GU 2023: Neeraj Agarwal, MD, FASCO Discusses Positive Results of Talazoparib Plus Enzalutamide

Neeraj Agarwal, MD, FASCO, describes the positive data from the TALAPRO-2 study on combination talazoparib and enzalutamide for metastatic castration-resistant prostate cancer as presented at the 2023 ASCO GU Cancers Symposium.
Dr. Agarwal is a medical oncologist and Presidential Endowed Chair at Huntsman Cancer Institute, as well as editor-in-chief for ASCO Daily News.